You are here

  • Home
  • Archive
  • Volume 4, Issue 1
  • Osteopontin is associated with disease severity and antiphospholipid syndrome in well characterised Swedish cases of SLE

Article metrics

Article menu

Download PDFPDF

Biomarker studies
Original research article
Osteopontin is associated with disease severity and antiphospholipid syndrome in well characterised Swedish cases of SLE

 

Online download statistics by month:

Online download statistics by month: July 2017 to March 2024

AbstractFullPdf
Jul 2017707020
Aug 201720520433
Sep 201719519850
Oct 201776759
Nov 2017848616
Dec 201711311425
Jan 2018525226
Feb 2018565014
Mar 201854589
Apr 201830326
May 201842433
Jun 201830315
Jul 2018333312
Aug 2018363628
Sep 2018282819
Oct 2018898938
Nov 2018888850
Dec 201817117132
Jan 201916416040
Feb 201912612417
Mar 2019777744
Apr 2019252327
May 2019303010
Jun 2019242214
Jul 2019212035
Aug 2019242439
Sep 2019222126
Oct 2019191937
Nov 2019323221
Dec 201920208
Jan 202037377
Feb 202029297
Mar 202021217
Apr 2020191913
May 2020171610
Jun 2020141311
Jul 202017189
Aug 2020998
Sep 2020262513
Oct 2020262614
Nov 202013142
Dec 202024237
Jan 202119198
Feb 202112116
Mar 202117176
Apr 2021550
May 202116116
Jun 202131317
Jul 202126244
Aug 2021882
Sep 202111118
Oct 2021272717
Nov 2021161613
Dec 202112123
Jan 202210102
Feb 202211104
Mar 202213134
Apr 202229261
May 2022292912
Jun 202228275
Jul 202215172
Aug 202227264
Sep 202240399
Oct 202227269
Nov 2022161614
Dec 2022181910
Jan 202317163
Feb 202327272
Mar 202329287
Apr 2023131216
May 202318179
Jun 202320184
Jul 2023232311
Aug 202313129
Sep 2023984
Oct 2023651
Nov 202316141
Dec 202315134
Jan 2024443
Feb 202419189
Mar 2024282711
Total300829721071